Filing Details

Accession Number:
0000791908-15-000091
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-17 18:03:17
Reporting Period:
2015-07-15
Filing Date:
2015-07-17
Accepted Time:
2015-07-17 18:03:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
791908 Xoma Corp XOMA Pharmaceutical Preparations (2834) 942756657
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1416176 John Varian C/o Xoma Corporation
2910 Seventh Street
Berkeley CA 94710
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2015-07-15 10,000 $1.24 562,414 No 4 M Direct
Common Shares Disposition 2015-07-15 10,000 $4.49 552,414 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Incentive Share Option (right to buy) Disposition 2015-07-15 10,000 $1.24 10,000 $1.24
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
70,392 2022-01-04 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 18,538 Indirect by 401(k)
Footnotes
  1. This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2014.
  2. This transaction was executed in multiple trades ranging at prices from $4.36 to $4.64. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Company or a security holder of the Company full information regarding the number of shares and prices at which the transactions were effected.
  3. Incentive Stock Option exercisable in conjunction with matching Non-Qualified Stock Option as to forty-eight (48) equal and consecutive monthly installments beginning one month after the date of grant.